Device Trial Radar · NCT05913479
Evaluation of the Efficacy and Safety of Mucogye® Gel as a Moisturizer
Last checked: Nov 20, 2026Latest source record: Feb 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
34
Actual
Start
Oct 10, 2023
Primary completion
Jan 2, 2026
Study completion Jan 2, 2026
Sponsor
- Lead sponsor
- BiocodexNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Voisin Consulting Life Science (VCLS)
- First posted
- Jun 22, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this post-Market Clinical Follow-up (PMCF) study for a class IIb medical device is to confirm th efficacy and safety of Mucogyne Gel as a moisturizer in women with vaginal dryness irrespective of the cause; when used in accordance with its approved labelling.
Conditions
- Vaginal Dryness
Interventions
Mucogyne GelDevice
At inclusion visit (V0), the Investigator will ask the subject to apply MUCOGYNE® Gel as described in the Instructions For Use, i.e., internally, one application 2 to 3 times a week until symptoms improve during 5 weeks (D35 +/- 3)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of the efficacy of MUCOGYNE® Gel intra vaginal applications on subjects' vaginal dryness irrespective of the cause over a 35-day period of use.Time frame: Day 0 to Day 35 +/- 3
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Dr Paul Lefevre's medical office
Caen, France
Dr Thierry KELLER's medical office
Colmar, France
Dr Christiane ARMAND's medical office
Écully, France
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.